• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    31.73 Up 0.78(2.52%) Dec 26, 4:00PM EST
    |After Hours : 31.73 Up 0.00 (0.01%) Dec 26, 4:42PM EST
    Add to Portfolio
    Prev Close:30.95
    Open:31.23
    Bid:19.35 x 100
    Ask:N/A
    1y Target Est:38.43
    Beta:2.88
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:31.12 - 32.05
    52wk Range:15.64 - 33.49
    Volume:627,891
    Avg Vol (3m):1,208,920
    Market Cap:3.17B
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACAD

    Comparison

    Symbol% ChgMkt Cap
    ACADUp 2.52%3.17B
    AZNUp 0.67%89.56B
    LLYUp 0.33%75.29B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28,329.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.91
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-1.70

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback